longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Haleon

HLN

9.2100.32% ( -0.030 )
Closed: Sep 16, 15:59:55 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 18.76, below the reasonable range, cheaper than 81.99% of the time in the past 1 years, and the industry ranks 34/257, the industry Median -1.31.

18.76xP/E
$9.24Stock price
$0.49Earnings per share
18.76xP/E
Stock price$9.24Earnings per share$0.49

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
20.13x
Typical range
18.95x–21.87x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0285684112

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
10.39x7.16%$188.10B
BMYUSBristol Myers Squibb
14.03x62.25%$130.18B
GSKUSGSK
15.81x6.56%$101.91B
UCBJYUSUCB S.A.
18.11x--$46.14B
HLNUSHaleon
18.76x2.92%$40.70B
OTSKYUSOtsuka Pharmaceutical
14.99x--$38.82B
DSNKYUSDaiichi Sankyo
19.83x--$33.29B
ZTSUSZoetis
11.51x6.81%$30.34B
ALPMYUSAstellas Pharma
11.43x--$26.64B
JAZZUSJazz Pharma
16.62x349.11%$15.63B
OPHLYUSOno Pharmaceutical
14.47x--$7.05B
INDVUSIndivior Pharmaceuticals
11.34x126.83%$4.04B
SNPHYUSSanten Pharmaceutical
14.52x--$3.59B
OGNUSOrganon
17.16x211.11%$3.59B
HRMYUSHarmony Biosciences
13.55x45.48%$2.46B
PBHUSPrestige Brands
12.86x7.48%$2.21B
GTBIFUSGreen Thumb Industries Inc.
13.53x--$1.71B
ANIPUSANI Pharma
16.27x49.55%$1.62B
PAHCUSPhibro Animal Health
14.26x26.75%$1.42B
CRONUSCronos
16.85x902.68%$1.18B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.